Zengxin Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zengxin Gao has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Yang Zhang
Department of Spinal Surgery, College of Medicine, Zhongda Hospital (First Affiliated Institution), Southeast University, Nanjing, People’s Republic of China
3 shared publicationsYucheng Gao
Department of Spinal Surgery, College of Medicine, Zhongda Hospital (First Affiliated Institution), Southeast University, Nanjing, People’s Republic of China
3 shared publications- Dongjin Wu
Department of Orthopaedics The Second Qilu Hospital of Shandong University Jinan Shandong China
2 shared publications Shuanggong Liu
Department of Orthopaedics, The Second Qilu Hospital of Shandong University, Jinan, China
2 shared publicationsYijun Rong
Department of Spinal surgery, Zhongda Hospital, College of Medicine, Southeast University, Dingjiaqiao 87, Nanjing, Jiangsu 210009, People's Republic of China, (First Affiliated Institution)
2 shared publicationsGuangxu Song
Department of Orthopedics, The Affiliated Hospital of Qingdao University, Qingdao, China
1 shared publication
Latest Publications
- Open Access
- 18 May 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
HDAC9 drives intervertebral disc degeneration by potentiating STAT1-mediated senescence and inflammation
Intervertebral disc degeneration is a leading cause of chronic low back pain, characterized by cellular senescence, extracellular matrix disintegration, and chronic inflammation. However, the key epigenetic regulators that orchestrate senescence and the resultant inflammatory cascade in disc degeneration remain poorly understood. This study aimed to investigate the pathological role and molecular mechanism of HDAC9 in IDD. We analyzed HDAC9 expression in aged degenerative discs. Using siRNA-mediated knockdown in primary cells, we assessed senescence, ECM, and inflammation. The mechanism was probed via co-immunoprecipitation, transcriptomics, and ELISA. HDAC9 expression was significantly upregulated in aged degenerative discs, correlating with enhanced cellular senescence and tissue destruction. Transcriptomic analysis revealed a profound pro-inflammatory and senescent signature in aged discs, with marked activation of the STAT1 signaling pathway. Knockdown of HDAC9 in aged cells attenuated senescence, reduced the expression of senescence markers and matrix catabolic enzyme, rescued proliferation deficits, and mitigated oxidative stress. Mechanistically, HDAC9 physically interacted with STAT1, and its knockdown decreased STAT1 phosphorylation. Both HDAC9 and STAT1 knockdown significantly suppressed the secretion of IL-6, TNF-α. Furthermore, classical STAT1 target genes were upregulated in aged discs. Our findings demonstrate that HDAC9 is a critical epigenetic driver of age-related IDD. It promotes cellular senescence and a pro-inflammatory microenvironment by interacting with and activating the STAT1 signaling pathway. Targeting the HDAC9-STAT1 axis may represent a novel therapeutic strategy for mitigating disc degeneration.
- 18 May 2026
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 21 (1)
Open AccessHDAC9 drives intervertebral disc degeneration by potentiating STAT1-mediated senescence and inflammation
Intervertebral disc degeneration is a leading cause of chronic low back pain, characterized by cellular senescence, extracellular matrix disintegration, and chronic inflammation. However, the key epigenetic regulators that orchestrate senescence and the resultant inflammatory cascade in disc degeneration remain poorly understood. This study aimed to investigate the pathological role and molecular mechanism of HDAC9 in IDD. We analyzed HDAC9 expression in aged degenerative discs. Using siRNA-mediated knockdown in primary cells, we assessed senescence, ECM, and inflammation. The mechanism was probed via co-immunoprecipitation, transcriptomics, and ELISA. HDAC9 expression was significantly upregulated in aged degenerative discs, correlating with enhanced cellular senescence and tissue destruction. Transcriptomic analysis revealed a profound pro-inflammatory and senescent signature in aged discs, with marked activation of the STAT1 signaling pathway. Knockdown of HDAC9 in aged cells attenuated senescence, reduced the expression of senescence markers and matrix catabolic enzyme, rescued proliferation deficits, and mitigated oxidative stress. Mechanistically, HDAC9 physically interacted with STAT1, and its knockdown decreased STAT1 phosphorylation. Both HDAC9 and STAT1 knockdown significantly suppressed the secretion of IL-6, TNF-α. Furthermore, classical STAT1 target genes were upregulated in aged discs. Our findings demonstrate that HDAC9 is a critical epigenetic driver of age-related IDD. It promotes cellular senescence and a pro-inflammatory microenvironment by interacting with and activating the STAT1 signaling pathway. Targeting the HDAC9-STAT1 axis may represent a novel therapeutic strategy for mitigating disc degeneration.
- 4 December 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 169, 115992
Calreticulin attenuates intervertebral disc degeneration by suppressing NLRP3 inflammasome activation through PINK1/Parkin-mediated mitophagy
- 4 December 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 169, 115992
Calreticulin attenuates intervertebral disc degeneration by suppressing NLRP3 inflammasome activation through PINK1/Parkin-mediated mitophagy
- Open Access
- 8 July 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-17
VMP1 attenuates ferroptosis and mitochondrial dysfunction in nucleus pulposus cells through the PINK1/Parkin-mediated mitophagy pathway
Background: Intervertebral disc degeneration (IVDD) is a multifactorial disorder and a leading contributor to chronic low back pain (LBP), highlighting the need for novel therapeutic strategies. Recent studies indicate that ferroptosis, driven by oxidative stress, plays a key role in the loss of nucleus pulposus cells (NPCs) during IVDD. Vacuole membrane protein 1 (VMP1), a membrane-associated regulator of autophagy, is known to influence various cellular processes. However, its role in IVDD remains unclear. This study investigates the function of VMP1 in IVDD and the mechanisms involved. Methods: We established a rat model of IVDD to investigate the correlation between VMP1 expression and ferroptosis during IVDD progression. In vitro, a ferroptosis model of NPCs was induced using tert-butyl hydroperoxide (TBHP) to examine the effects of VMP1 knockdown on NPC apoptosis, extracellular matrix (ECM) degradation, ferroptosis, PINK1/Parkin-dependent mitophagy, and mitochondrial function. Furthermore, cyclosporin A (CsA), a mitophagy inhibitor, was employed to explore the role and potential mechanisms of VMP1 overexpression in regulating PINK1/Parkin-mediated mitophagy, mitochondrial function, and ferroptosis. Results: In this study, we observed a significant downregulation of VMP1 expression in a rat model of IVDD, which was accompanied by the occurrence of ferroptosis. Subsequent experiments revealed that VMP1 knockdown aggravated apoptosis and ECM degradation in NPCs. Furthermore, we demonstrated that VMP1 silencing promoted ferroptosis, inhibited PINK1/Parkin-dependent mitophagy, and impaired mitochondrial function in NPCs. In contrast, VMP1 overexpression enhanced PINK1/Parkin-mediated mitophagy, mitigated mitochondrial dysfunction, and suppressed ferroptosis. Notably, these protective effects were abolished by treatment with CsA. Conclusions: This study demonstrates that VMP1 alleviates IVDD by inhibiting ferroptosis and mitochondrial dysfunction in NPCs, a protective effect mediated through the promotion of PINK1/Parkin-dependent mitophagy. Our study underscores the pivotal role of VMP1 in coordinating mitophagy and ferroptosis during IVDD pathogenesis, identifying VMP1 as a potential therapeutic target for IVDD treatment. Graphical
- 8 July 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-17
Open AccessVMP1 attenuates ferroptosis and mitochondrial dysfunction in nucleus pulposus cells through the PINK1/Parkin-mediated mitophagy pathway
Background: Intervertebral disc degeneration (IVDD) is a multifactorial disorder and a leading contributor to chronic low back pain (LBP), highlighting the need for novel therapeutic strategies. Recent studies indicate that ferroptosis, driven by oxidative stress, plays a key role in the loss of nucleus pulposus cells (NPCs) during IVDD. Vacuole membrane protein 1 (VMP1), a membrane-associated regulator of autophagy, is known to influence various cellular processes. However, its role in IVDD remains unclear. This study investigates the function of VMP1 in IVDD and the mechanisms involved. Methods: We established a rat model of IVDD to investigate the correlation between VMP1 expression and ferroptosis during IVDD progression. In vitro, a ferroptosis model of NPCs was induced using tert-butyl hydroperoxide (TBHP) to examine the effects of VMP1 knockdown on NPC apoptosis, extracellular matrix (ECM) degradation, ferroptosis, PINK1/Parkin-dependent mitophagy, and mitochondrial function. Furthermore, cyclosporin A (CsA), a mitophagy inhibitor, was employed to explore the role and potential mechanisms of VMP1 overexpression in regulating PINK1/Parkin-mediated mitophagy, mitochondrial function, and ferroptosis. Results: In this study, we observed a significant downregulation of VMP1 expression in a rat model of IVDD, which was accompanied by the occurrence of ferroptosis. Subsequent experiments revealed that VMP1 knockdown aggravated apoptosis and ECM degradation in NPCs. Furthermore, we demonstrated that VMP1 silencing promoted ferroptosis, inhibited PINK1/Parkin-dependent mitophagy, and impaired mitochondrial function in NPCs. In contrast, VMP1 overexpression enhanced PINK1/Parkin-mediated mitophagy, mitigated mitochondrial dysfunction, and suppressed ferroptosis. Notably, these protective effects were abolished by treatment with CsA. Conclusions: This study demonstrates that VMP1 alleviates IVDD by inhibiting ferroptosis and mitochondrial dysfunction in NPCs, a protective effect mediated through the promotion of PINK1/Parkin-dependent mitophagy. Our study underscores the pivotal role of VMP1 in coordinating mitophagy and ferroptosis during IVDD pathogenesis, identifying VMP1 as a potential therapeutic target for IVDD treatment. Graphical